Join to View Full Profile
7500 Mercy RdSte 1300Omaha, NE 68124
Phone+1 402-393-3110
Fax+1 402-393-4499
Dr. Block is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1980 - 1981
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1980- Rush University Medical CenterResidency, Internal Medicine, 1976 - 1979
Albany Medical CollegeClass of 1976
Certifications & Licensure
IA State Medical License 1989 - 2026
NE State Medical License 1989 - 2026
WI State Medical License 1980 - 2025
IL State Medical License 1977 - 1993
PA State Medical License 1983 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer Start of enrollment: 2012 Apr 01
- Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Start of enrollment: 2013 Apr 01
- A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
- Join now to see all
Publications & Presentations
PubMed
- Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia
Cancer. 2024-05-15 - 1 citationsReply to T. Shimoi et al and Y. Shimanuki et al.Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, William Fraser Symmans, Ben Ho Park
Journal of Clinical Oncology. 2021-09-23 - 10 citationsPreservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when adde...Volkmar Mueller, Andrew M Wardley, Elisavet Paplomata, Erika Hamilton, Amelia Zelnak
European Journal of Cancer. 2021-06-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
